The FDA, regulation, and the risk of stroke.
Fleming
G A
GA
D001067:Appetite Depressants / Q000009:adverse effects*; D019587:Dietary Supplements / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004365:Drugs, Chinese Herbal / Q000009:adverse effects*; D029790:Ephedra sinica; D004809:Ephedrine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D014663:Nasal Decongestants / Q000009:adverse effects; D010665:Phenylpropanolamine / Q000009:adverse effects*; D028321:Plant Preparations; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration; D029789:Ephedra
D001067:Appetite Depressants; D004365:Drugs, Chinese Herbal; D014663:Nasal Decongestants; D028321:Plant Preparations; D010665:Phenylpropanolamine; C099950:Ephedrae herba; D004809:Ephedrine